EconomyMarkets

Bargain-Hunting Without Exuberance as Defensives Lead By Investing.com

© Reuters.

By Geoffrey Smith 

Investing.com — The rout in tech stocks in the U.S. over the last day has been a stiff test of nerve for European markets – but one to which they appear to be equal, at least for now.

Having fallen in knee-jerk fashion in line with the Nasdaq and the other big U.S. boards on Tuesday, European markets were all firmly back in the green as of 5:15 AM ET (0915 GMT) on Wednesday, helped by a smart bounce in Nasdaq futures as early birds in the U.S. logged on.

Even so, there was a heavy preference for defensive names such as telecoms, health and consumer staples. 

Among the notable outperformers were Orange (PA:) and Deutsche Telekom (DE:) stock, up 3.6% and 2.3%, respectively, while Reckitt Benckiser (LON:) was up 2.3%, Unilever (NYSE:) stock was up 1.5% and Nestle (SIX:) stock up 1.2%.

The ‘new defensives’ – especially renewable energy stocks backed by a wall of ESG-focused money – were also well bid, with EDP Renovaveis (LS:) stock up 2.8% and wind turbine makers Vestas Wind Systems (CSE:) and Siemens Gamesa (MC:) both up more than 2%.

By contrast, the more volatile cyclical stocks were subdued, as a German auto summit ended without any concrete offer of fresh government support, and banks consolidated after the M&A excitement in Spain (Caixabank (MC:) still gained 1.2% on reports that it’s looking to improve the terms of its mooted tie-up with Bankia (MC:)). Aerospace names continued to underperform after fresh reports of production trouble at Boeing (NYSE:), one of their biggest customers. Meggitt (LON:), Senior (LON:) and Rolls Royce (LON:) all fell by 4% or more.

The benchmark was up 0.7%, still stuck in the narrow range it’s been in since June. For most of the last three months, that’s been a source of frustration for many, who have been forced to watch U.S. stocks disappear over the horizon. However, given events stateside over the last three days, European investors will settle for range trading quite happily, thank you very much.

Despite a valuation gap to the U.S. that is still miles wide, the appetite to push European stocks higher is limited. Coronavirus case numbers are surging in Spain, France and the U.K., and rising less dramatically elsewhere. Even though hospitalizations and death rates still remain well below the levels of spring, the fear of starting the flu season with a high level of community spread is evident.

What’s also increasingly evident is that investors have woken up to the risks of the latest Brexit drama, with sliding and U.K. stocks clearly underperforming – the domestic-focused was the only major index in the red on Wednesday morning.

However, even here, it’s the government’s erratic policy on lockdowns that appears to be the more important factor. Some of the biggest losers on Tuesday were WH Smith (LON:), sandwich bar operator SSP Group (LON:) and Trainline (LON:), all of them heavily exposed to mobility levels.  They fell by more than AstraZeneca (NYSE:), despite the amount that’s been bet on it winning the race for a successful Covid-19 vaccine.

With the U.S. markets in flux and a European Central Bank meeting in 24 hours, it isn’t surprising that Europeans are happy to sit on their hands. But a pattern of defensive outperformance is quietly asserting itself nonetheless.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close